Journal of Radiation Protection and Research

The Korean Association for Radiation Protection (대한방사선방어학회)
권호 표지
DOI QR코드

DOI QR Code

Calculation of an Indicator for Early Death Using Atomic Bomb Survivors' Data

  • Received : 2021.03.31
  • Accepted : 2021.08.30
  • Published : 2022.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background: A comprehensive, traceable, and easy-to-understand radiation risk indicator is desired for radiological protection. The early-onset hypothesis could be used for this purpose. Materials and Methods: An indicator for early death (IED) was developed and calculated using the epidemiological dataset from the 14th Report of the Life Span Study (LSS) of Hiroshima and Nagasaki. By clarifying the calculation process, IED for all-cause mortality was estimated. In addition, the characteristics of IED for solid cancer mortality and cardiovascular mortality as well as those of men and women, and their dependence on age at exposure were investigated for detailed analysis. Results and Discussion: The IED for all-cause mortality was estimated to be approximately 4 years for an acute radiation exposure of 1 Gy regardless of the fitting dose range. The cumulative death rate for all solid cancers also indicated the early-death tendency (approximately 7-10 years at 1 Gy). Although, there is a slight difference in the characteristics of the risk obtained from the LSS study and this study, it is considered that the IED in a unit of years can also be used to show the overall picture of risk due to radiation exposure. Conclusion: We developed and calculated the indicator for early death, IED, for the cumulative mortality rate of all causes of death, all solid cancers, and circulatory diseases. The quantitative values of IED were estimated to be 4 years for all causes of death, 7-10 years for all solid cancers. IED has an advantage for intuitively understanding the meaning of radiation risk since it can be obtained by a simple and traceable method.

Keywords

Acknowledgement

This report makes use of data obtained from the Radiation Effects Research Foundation (RERF), Hiroshima and Nagasaki, Japan. RERF is a private, non-profit foundation funded by the Japanese Ministry of Health, Labour and Welfare (MHLW) and the US Department of Energy (DOE), the latter in part through DOE Award DE-HS0000031 to the National Academy of Sciences. The conclusions in this report are those of the authors and do not necessarily reflect the scientific judgment of RERF or its funding agencies. We would like to express our sincere appreciation to Dr. Nori Nakamura and Dr. Ritsu Sakata for their helpful suggestions.

References

  1. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and effects of ionizing radiation (Annex A). New York, NY: United Nations Scientific Committee on the Effects of Atomic Radiation; 2012.
  2. The 2007 recommendations of the International Commission on Radiological Protection: ICRP publication 103. Ann ICRP. 2007;37(2-4):1-332. https://doi.org/10.1016/j.icrp.2007.11.001
  3. Gonzalez AJ, Akashi M, Boice JD Jr, Chino M, Homma T, Ishigure N, et al. Radiological protection issues arising during and after the Fukushima nuclear reactor accident. J Radiol Prot. 2013;33(3):497-571. https://doi.org/10.1088/0952-4746/33/3/497
  4. Authors on behalf of ICRP, Stewart FA, Akleyev AV, Hauer-Jensen M, Hendry JH, Kleiman NJ, et al. ICRP publication 118: ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs: threshold doses for tissue reactions in a radiation protection context. Ann ICRP. 2012;41(1-2):1-322. https://doi.org/10.1016/j.icrp.2012.02.001
  5. Nakamura N. A hypothesis: radiation carcinogenesis may result from tissue injuries and subsequent recovery processes which can act as tumor promoters and lead to an earlier onset of cancer. Br J Radiol. 2020;93(1115):20190843. https://doi.org/10.1259/bjr.20190843
  6. Tanaka S, Tanaka IB III, Sasagawa S, Ichinohe K, Takabatake T, Matsushita S, et al. No lengthening of life span in mice continuously exposed to gamma rays at very low dose rates. Radiat Res. 2003;160(3):376-379. https://doi.org/10.1667/RR3042
  7. Ozasa K, Shimizu Y, Suyama A, Kasagi F, Soda M, Grant EJ, et al. Studies of the mortality of atomic bomb survivors, Report 14, 1950-2003: an overview of cancer and noncancer diseases. Radiat Res. 2012;177(3):229-243. https://doi.org/10.1667/RR2629.1
  8. Cologne JB, Preston DL. Longevity of atomic-bomb survivors. Lancet. 2000;356(9226):303-307. https://doi.org/10.1016/S0140-6736(00)02506-X
  9. Sakata R, Shimizu Y, Soda M, Yamada M, Hsu WL, Hayashi M, et al. Effect of radiation on age at menopause among atomic bomb survivors. Radiat Res. 2011;176(6):787-795. https://doi.org/10.1667/RR2676.1
  10. Sakata R, McGale P, Grant EJ, Ozasa K, Peto R, Darby SC. Impact of smoking on mortality and life expectancy in Japanese smokers: a prospective cohort study. BMJ. 2012;345:e7093. https://doi.org/10.1136/bmj.e7093
  11. ICRP. The optimisation of radiological protection: broadening the process: ICRP publication 101: approved by the Commission in September 2005. Ann ICRP. 2006;36(3):65, 71-104. https://doi.org/10.1016/j.icrp.2006.06.003
  12. International Radiation Protection Association. IRPA guiding principles for radiation protection professionals on stakeholder engagement [Internet]. Saint Denis, France: International Radiation Protection Association; 2008 [cited 2022 Feb 11]. Available from: https://www.irpa.net/docs/IRPA%20Stakeholder%20Engagement%20Guiding%20Principles%20(2008).pdf.
  13. Cullings HM, Fujita S, Funamoto S, Grant EJ, Kerr GD, Preston DL. Dose estimation for atomic bomb survivor studies: its evolution and present status. Radiat Res. 2006;166(1 Pt 2):219-254. https://doi.org/10.1667/RR3546.1
  14. 1990 Recommendations of the International Commission on Radiological Protection. Ann ICRP. 1991;21(1-3):1-201. https://doi.org/10.1016/0146-6453(91)90065-O
  15. Shimizu Y, Kodama K, Nishi N, Kasagi F, Suyama A, Soda M, et al. Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003. BMJ. 2010;340:b5349. https://doi.org/10.1136/bmj.b5349
  16. Ulanowski A, Kaiser JC, Schneider U, Walsh L. On prognostic estimates of radiation risk in medicine and radiation protection. Radiat Environ Biophys. 2019;58(3):305-319. https://doi.org/10.1007/s00411-019-00794-1
  17. Thomas D, Darby S, Fagnani F, Hubert P, Vaeth M, Weiss K. Definition and estimation of lifetime detriment from radiation exposures: principles and methods. Health Phys. 1992;63(3):259-272. https://doi.org/10.1097/00004032-199209000-00001